Table 1. Characteristics of Study Subjects Diagnosed with Melanoma (n = 18,884)
CharacteristicsPatients
No.%
Prior physician visits
    Neither PCP nor dermatologist2,41912.8
    PCP only9,55150.6
    Dermatologist only9945.3
    Both PCP and dermatologist5,92031.3
Age at diagnosis (years)
    67–758,67645.9
    76–857,84741.6
    ≥862,36112.5
Sex
    Male11,28359.7
    Female7,60140.3
Race/ethnicity
    Non-Hispanic white17,86694.6
    Bon-Hispanic black1150.6
    Hispanic3081.6
    Asian/American Indian/Pacific Islander1100.6
    Other4852.6
Marital status
    Single (never married)1,1296.0
    Married9,50050.3
    Separated/divorced6713.6
    Widowed3,64019.3
    Unknown3,94420.9
MSA of residence
    Large metropolitan10,57056.0
    Metropolitan5,55229.4
    Urban1,1175.9
    Less urban1,2946.9
    Rural3501.9
    Unknown10.0
Year of diagnosis
    1994–19973,35917.8
    1998–20003,80220.1
    2001–200511,72362.1
Histologic type
    Melanoma NOS8,91147.2
    Nodular melanoma1,7649.3
    Superficial spreading4,57924.2
    Lentigo maligna2,22011.8
    Acral melanoma2661.4
    Other1,1446.1
Stage at diagnosis*
    Local, thin8,98147.6
    Local, intermediate3,24217.2
    Local, thick2,00610.6
    Regional2,76614.6
    Distant9074.8
    Unknown9825.2
Charlson Comorbidity Index
    011,32460.0
    14,31722.9
    ≥23,24317.2
Influenza vaccination8,01742.5
    No10,86757.5
    Yes
Surgery
    Surgery with wide margin10,89357.7
    Surgery without wide margin6,47134.3
    No surgery1,4547.7
    Unknown surgery660.3
Lymph nodes removed
    Yes4,21322.3
    No14,32875.9
    Unknown3431.8
Radiation
    Yes4882.6
    No18,13596.0
    Unknown2611.4
  • * Thin lesions are defined as Breslow thickness <1 mm, intermediate are 1 to 2 mm, and thick are >2 mm.

  • MSA, metropolitan statistical area; NOS, not otherwise specified; PCP, primary care physician.